Histogenics (HSGX) – FDA
-
Histogenics (HSGX) Gains as Partner Granted FDA Orphan Drug Designations
-
Histogenics (HSGX) Says FDA Indicated Additional Trial Needed to Complete Submission of BLA for NeoCart
-
-
-
-
-
-
-
-
-
Back to HSGX Stock Lookup